The Dow (DJI) decided that, on a work night, after weeks of not feeling too hot, it should have a night on the town. After several brewskis, three long-islands, and something called a “dirty mark-tini,” the Dow (DJI) was done for the night. “I think I need to call a cab,” the Dow said, as the sentiment fell on the deaf ears of the other patrons of the bar. The car arrived, the Dow went home and passed out within moments of hitting the pillow.
When the index awoke Wednesday morning, it was covered in bruises and cuts, having fallen 600 points, a 2.4% drop. The Dow checked its phone to discover that its fellow indices, the S&P 500 (SPX) and the Nasdaq both fell 3% and 4% respectively, with the Nasdaq’s (IXIC) drop the worst since August 2011.
As a result of the Nasdaq’s injuries, the tech-heavy index saw many of its holdings suffer disappointing losses as well. Though Netflix started off with strong earnings last week after the announcement of a boost in subscribers, it was fugacious occurrence for Netflix and the FANG stocks Facebook (FB), Amazon (AMZN), and Google (GOOG). The popular streaming site fell more than 9% on Wednesday, down a total of 17% for the week thus far.
Choose Your Tech Stocks Wisely, Young Padawan
Market concerns are largely based on worries of rising interest rates, reactionary regulating of data in response to Facebook’s (the F in FANG) unresolved data issues, as well as the ongoing trade war between the U.S. and China.
- Facebook’s (FB) shares fell 4%, closing at $146.04 per share
- Amazon (AMZN) dove 5%, trading at $1,664.20 per share,
- Apple (AAPL), set to report earnings early next week, fell 3%, closing $215.09 per share
In the past, investors and analysts have revered tech stocks for their strength and immunity from market trends, but some believe that tech is destined to turn bearish given its success over the last decade.
“You didn’t have to be discerning with tech before since it has been doing so well for the past decade. But now, people have to look at the various valuations and how each company is doing.”
–Sylvia Jablonski, institutional ETF Strategist, Direxion
The key concern for tech sector market fanboys relates to internet privacy laws and how companies like Facebook and Google are in the doghouse until they prove to consumers that their user data is safe from cyber-terrorism.
In the case of Google (GOOG), the industry-leading search engine has faced massive criticism for its failure to disclose what information it records from its users. According to an Associated Press investigation conducted in August, “Google saves your location history even if you’ve paused ‘location history’ on mobile devices.” The investigation goes on to point out that by storing your “minute-by-minute travel information,” Google (GOOG) has assisted local police in determining the location of suspects. While valiant, this represents a major risk for consumer privacy, and investors like their privacy, let me tell you.
Amazon (AMZN), Though…
As privacy scandals arouse increased regulations for major tech companies, market concerns are spreading through space like a virus. Meanwhile, Amazon (AMZN) is proving unstoppable, with the company making move seemingly every day. As of Tuesday, the world’s leading e-commerce site is up 49% year-to-date, as it plans to expand its global grasp with the building of its new HQ2 headquarters. The company will reportedly release the location of its new campus before the end of next month, with leading locations including Austin, Boston, and Northern Virginia.
The creation of the new location will cost approximately $5 billion and will create 50,000 more employment opportunities for the company. Recent reports indicate that Amazon (AMZN) is one of the most desirable companies to work for, and HQ2 will surely keep this allure alive.
The fate of the tech sector is not written in stone. As we look to the future, we will hopefully see an end to the U.S./China trade war, ultimately resulting in lower debt yields and decreases in interest rates. If anything, the recent downward trend of major U.S. indices represents nothing more than a panic attack “rather than the beginning of a bear market,” according to CNBC analysts.
It’s always darkest before the dawn and the Dow, members of the FANG group, and our spirits will rise again.
Biotechnology Could Cure It All
Nearly two-thousand years ago, give or take several minutes, Hippocrates taught that human existence was centered around the four elements — earth, water, fire, and air — which in the human body was represented by the four basic humors: blood, phlegm, black bile, yellow bile. Hippocrates explained that each humor was located in a specific organ of the human body and each related to its own personality type — sanguine, phlegmatic, melancholic, and choleric.
‘Therefore, if someone was sick, Hippocrates taught that this indicated an imbalance in one of the four
Suffice to say that the medical field has moved forward since 460 BC, and recently, these advancements have occurred in the biotechnology industry. Though biotech is a relatively new field, it possesses great potential for the future of medicine. One of the more recent breakthroughs in biotech stems from something called pharmacogenomics, or the study of how genetics affect a person’s response to drugs. This new field combines the science of developing drug treatments and research conducted on human genetics and their functions.
According to the U.S. National Library of Medicine, most drugs currently available on the market are branded as “one size fits all,”meaning that this specific treatment was created to cure a certain ailment for anyone who takes it. However, as scientists in the pharmacogenomics field are discovering, not everyone reacts the same to certain drugs.
For example, if two individuals are having an allergic reaction and both ingest an anti-histamine, it’s possible that it will help one person feel better, while causing adverse side-effects to the other person. By studying a person’s genetic coding, medical experts are better able to predict how a medication will effect a particular person.
Ironically enough, as new technologies and inventive approaches to curing diseases come to light, medical researchers are discovering new diseases that seek to test all the progress we’ve made thus far. The practices of medicine have taken massive strides over the past few generations through the pioneering of biotechnology research and other incredible advancements, but regardless of these steps forward, it is up to companies in the healthcare industry to responsibly tend to the needs of their patients.
Premier Health Group Inc. (OTC: PHGRF) / (CSE: PHGI) / (6PH.F) is a Canadian publicly traded company strategically poised to take advantage of lucrative business opportunities in the global healthcare industry. The Company is working to develop innovative healthcare approaches that combine human skill-based expertise with emerging technologies. What sets the Company apart from others in the field is that Premier is focused on developing their healthcare platform with a patient centric focus, looking to restore power back to the patients. For far too long, patients have been at the mercy of pharmaceutical companies who, by virtue of their capital, have maintained a chokehold on the price of drugs that patients need to stay healthy.
In addition to rising treatments costs, as the global population increases, there are less primary physicians available for consumers looking to be cured. Through the use of Premier Health Group Inc. (OTC: PHGRF) / (CSE: PHGI) / (6PH.F) HealthVue app, patient can see their physician, access their charts & lab results, chat securely with clinical staff, reorder prescriptions and share remote health monitoring data with their doctor – all at their fingertips. The HealthVue app utilizes a virtual care platform designed to be easy to use and to improve a patient’s access to primary care.
In addition these advanced healthcare solutions, the Company shared, in their most recent corporate update, that they plan on utilizing artificial intelligence to assist in virtually triaging the needs of their patients. Using their Healthvue app, the patient will answer a series of questions which will be relayed to the physician, along with a differential on possible diagnoses. This information will be pre-populated to the physicians charting system and will provide key patient information prior to the scheduled virtual visit, saving them a considerable amount of time and allowing more time for patient interaction.
Pursuant to an agreement between MIDAM VENTURES, LLC and Premier Health Group Inc. we were hired for a period from 10/1/2018 – 4/1/2019 to publicly disseminate information about Premier Health Group Inc. including on the Website and other media including Facebook and Twitter. We were paid $300,000 ( CASH) for & were paid “500,000” shares of restricted common shares (as of 1/2/2019). We own zero shares of Premier Health Group Inc., which we purchased in the open market. Once the (6) Six-month restriction is complete on 4/1/2019 we plan to sell the “500,000” shares of Premier Health Group Inc. that we hold currently in restricted form during the time the Website and/or Facebook and Twitter Information recommends that investors or visitors to the website purchase without further notice to you. We may buy or sell additional shares of Premier Health Group Inc. in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. Please click here for full disclaimer.
Stock Price Newsletter – February 21, 2019
Mueller Investigation Is Almost Ready
A half-witted, know-nothing playwright by the name of William Shakespeare once wrote that “these violent delights have violent ends.” The line, taken from Shakespeare’s Romeo and Juliet, also featured in Westworld, depicts a scene in which Friar Laurence cautions Romeo into falling for Juliet because his love may catalyze his own violent end. I attribute the words of Shakespeare to the current predicament facing President Donald Trump and his administration. In the two or so years since Trump took office, special counsel Robert Mueller has worked without end to investigate whether the Trump administration colluded in any way, shape, or form, with Russia during the 2016 presidential election.
After countless subpoenas and inducements of former Trump associates and administration members, sources indicate that Mueller’s long nights away from the family could soon be over. Towards that end of January, Roger Stone, a former associate of Donald Trump before he became president, was indicted on charges of seeking stolen emails from WikiLeaks that could damage Trump’s opponents during the 2016 presidential election season.
Per the official language of the indictment:
“…After the 2016 U.S. presidential election, the U.S. House of Representatives Permanent Select Committee on Intelligence, the U.S. Senate Select Committee on Intelligence, and the Federal Bureau of Investigation opened or announced their respective investigations into Russian interference in the 20126 U.S. presidential election…Stone took steps to obstruct these investigations….He made false statements to the HPSCI about his interactions regarding WikiLeaks, and falsely denied possessing records that contained evidence…”
-Robert Stone indictment
The indictment went on to explain that Stone attempted to persuade a witness to provide false testimony and withheld pertinent information from federal investigators. According to several sources, Stone was arrested by the FBI Friday morning while drinking his morning coffee at his home in Florida. Stone’s attorney immediately attempted to defuse any public sentiment stirring up connecting Stone to special counsel Mueller’s investigation, suggesting that Stone’s indictment “focuses on allegedly false statements…made to Congress,” and has nothing to do with Russian collusion.
According to CNN, Attorney General Bill Barr is limbering up in preparation to announce as early as next week the completion of Robert Mueller’s investigation, “with plans for Barr to submit to Congress soon after a summary” of the confidential report is prepared. Interestingly enough, though the details of the report concern both the American people and its presiding government, under special counsel regulations, Mueller must submit his “report” to the attorney general and the law doesn’t require this document to be shared with anyone.
Barr is under no formal obligation to publicly share the report, but I can already assume that members of the Democratic leadership will be banging on his office door until he throws them a bone.
The question on everyone’s mind is, what Mueller discovered in his lengthy investigation. Mueller was appointed to the case on May 17, 2017, and in years following this date, Mueller has had his hands full. Early last week, Mueller’s office filed its sentencing memorandum against Paul Manafort, Trump’s former campaign manager, who will be sentenced next month in federal district court in the District of Columbia.
“For a decade, Manafort repeatedly violated the law. Considering only the crimes charged in this district, they make plain that Manafort chose to engage in a sophisticated scheme to hide millions of dollars from United States authorities. The sentence in this case must take into account the gravity of this conduct, and serve to both specifically deter Manafort and those who would commit a similar series of crimes.”
–sentencing memo from Robert Mueller
As for the findings of Mueller’s investigation, we will have to wait and see how Attorney General Barr chooses to go about sharing the report, if he ends up sharing the information at all. The information could disturb the Trump presidency and possibly give Democrats grounds for introducing articles of impeachment.
Search Stock Price (StockPrice.com)
Editorials2 months ago
Multi-Trillion Dollar Industry Providing Massive Opportunity in 2019 & Beyond
Featured4 months ago
Opportunity Ahead → Telemedicine the Future of Primary Care
Sponsored Content4 months ago
Special Delivery! On-Demand Tech Companies Hit Billion-Dollar Valuations; Here’s How Investors Can Capitalize In The Market
Featured4 months ago
Premier Health Group Inc. (OTC: PHGRF) (CSE: PHGI) Announces Plans to Enter Canadian Pharmacy & Drug Store Market
Newsletter4 months ago
Stock Price: Newsletter Tuesday 11/5/2018
Editorials5 months ago
2 NAFTA 2 Furious!
Editorials5 months ago
Brews with Brett; Why the Supreme Court Nominee’s Favorite Drink May Be His Downfall
Editorials5 months ago
China Offers New “Spy-cy” Chip Flavor, Apple & Amazon Can’t Stand Heat